IBRN vs. IHE ETF Comparison

Comparison of iShares Neuroscience and Healthcare ETF (IBRN) to iShares U.S. Pharmaceutical ETF (IHE)
IBRN

iShares Neuroscience and Healthcare ETF

IBRN Description

iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$25.99

Average Daily Volume

353

Number of Holdings *

9

* may have additional holdings in another (foreign) market
IHE

iShares U.S. Pharmaceutical ETF

IHE Description The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$68.08

Average Daily Volume

34,586

Number of Holdings *

10

* may have additional holdings in another (foreign) market
Performance
Period IBRN IHE
30 Days -4.46% -4.82%
60 Days 2.04% -5.55%
90 Days 1.20% -4.97%
12 Months 24.40% 17.96%
1 Overlapping Holdings
Symbol Grade Weight in IBRN Weight in IHE Overlap
ITCI B 4.16% 3.33% 3.33%
Compare ETFs